Le Roy et al; Pediatric Low Dose Multiphasic Coronary CT C ongenital heart disease (CHD) is the leading cause of congenital abnormalities (8/1000 of live births). 1 Coronary artery anomalies represent 0.17% of the overall pediatric population 2 and are associated with an increased risk of heart failure, valve disease, arrhythmia, or sudden death. 3 Over the past 2 decades, coronary computed tomography angiography (CCTA) has progressively replaced cardiac catheterization in nearly all situations involving coronary arteries among children with CHD. This includes abnormal left or right coronary artery arising from the pulmonary artery, syncope or sudden death with suspected interarterial or intramural coronary artery, possible existence of a major coronary artery branch crossing the infundibulum before surgical repair of tetralogy of Fallot, and follow-up after surgical reimplantation of coronary arteries. 4, 5 In these situations, CCTA has progressively been used as a diagnostic tool complementary to echocardiography. 5, 6 As a noninvasive and widely available technique, CCTA provides superior spatial resolution with multiple reconstruction possibilities. 6 It may be a good alternative to overcome the limited acoustic window and poor extracardiac structure visualization provided by echocardiography. 6 The recent development of wide-detector scanner allows volumetric acquisitions within a single heartbeat, avoiding stair-step artifacts, reducing radiation exposure, and improving uniform contrast enhancement. 7 However, CCTA performed on children still raises 2 major difficulties: (1) The use of ionizing radiation in young patients involves a highly radiosensitive population, potentially subject to multiple examinations during their follow-up 2, 8 and (2) There are technical issues related to young patients, such as breath-holding issues, uncontrolled movements during acquisition, elevated heart rates (HR), and visualization of small structures.
Technically, a cardiac CTA is currently performed in 3 ways depending on how the ECG data are used:
1. CTA without ECG synchronization: during the entire acquisition duration, the positions of the shifting vessels are averaged in a single reconstructed volume, causing important motion artifacts. Therefore, this technique is not suitable for coronary artery assessment in patients with a high HR, such as children with CHD, 9 despite moderate delivered doses, from 0.5 to 4.8 mSv. 7, 10, 11 2. Retrospective ECG-gated acquisitions: ECG synchronization is only used retrospectively, at the reconstruction stage, to differentiate data coming from each cardiac phase separately. Every cardiac phase is reconstructed one at a time and is available with high image quality. It delivers a substantial amount of radiation, from 3 to 11 mSv 8, [12] [13] [14] for pediatric patients: its use should be limited to least performing CT scanners and applied with ECG dose modulation. 3. Prospective ECG-triggered acquisitions. The ECG synchronization is used to trigger irradiation at the right moment to select a specific cardiac phase. During other phases of low interest, irradiation can either be halted or only be reduced, leading to monophasic (without any padding) or multiphasic acquisition, respectively. Multiphasic acquisitions give more flexibility for diagnosis at the cost of an increased dose to the patient. Doses from 0.8 to 4 mSv have been reported for pediatric populations. 6, 8, [13] [14] [15] Prospective ECG-triggered monophasic acquisitions are well adapted to regular and moderate HR, such as in adult patients. However, children with CHD do not present equivalent cardiac characteristics; they have higher and unstable HR, involving faster coronary artery velocity. 16, 17 Coronary arteries are then harder to acquire without motion artifacts, because of the limited temporal resolution of CT. This may finally lead to 11% to 15% of nondiagnostic or suboptimal quality examinations. 11, 13, 18 Therefore, a hybrid method between monophasic and multiphasic acquisitions could combine the advantages of both techniques providing additional-but
CLINICAL PERSPECTIVE
Coronary computed tomography angiography has progressively replaced cardiac catheterization in nearly all situations involving coronary arteries among children with congenital heart disease and is now used as a diagnostic tool complementary to echocardiography. Performing coronary computed tomography angiography in such pediatric population is technically challenging, because of complex anatomies, breath-holding issues, uncontrolled movements, elevated heart rates, and visualization of small structures. Therefore, better (higher image quality) and safer (lower radiation dose) coronary computed tomography angiography practices are needed. Recent computed tomography technology allows further personalization of cardiac acquisitions and makes their application possible in daily clinical routine. The COROPEDIA trial provides a comprehensive set of parameters to perform pediatric coronary computed tomography angiography as a function of a patient's cardiac characteristics. Results suggest that duration and position of the acquisition window within cardiac cycle should be adapted to patient's heart rate and variability, to maximize structure visualization. Besides, carefully selected multiphasic acquisitions should be performed to provide more information to clinicians while keeping submillisievert dose levels. strictly selected-cardiac phases compared with monophasic acquisitions, while maintaining irradiation at low dose levels compared with a regular multiphasic acquisition. Moreover, some studies have suggested adapting the acquisition window within the cardiac cycle as a function of patients' HR and HR variability. [19] [20] [21] [22] However, these studies did not include pediatric patients with the use of CT.
By combining these 2 novel aspects in a single acquisition protocol, the COROPEDIA trial (Observational Study for Feasibility and Performance of Sub-millisievert Coronary Computed Tomography Angiography for Coronary Artery Anomalies in Paediatric Patients) aimed to prospectively assess the feasibility of this new way of performing submillisievert CCTA on children with CHD.
METHODS

Study Design and Population
This cross-sectional study was performed from May 2017 to December 2017 in a tertiary care pediatric and congenital cardiology reference center (Montpellier University, France). Children with CHD younger than 18 years old and with a suspected or confirmed coronary artery anomaly were prospectively recruited. Only those requiring a CCTA as part of their follow-up were eligible. Children with absolute contraindication for angiography CT (allergy to iodinated contrast material) were not eligible.
Formal Aspects
The study was conducted in compliance with the Good Clinical Practices protocol and Declaration of Helsinki principles. It was approved by the French South-East III Ethics Committee (2017-A00909-44) and registered. Informed consent was obtained from all parents or legal guardians. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
CT Pediatric Protocol
The existing protocol in our institution was used for this study. A complete physical examination and an ECG were systematically performed before CCTA. One hour before CCTA, eligible children with an HR above 70 beats per minute (bpm) received a single dose of β-blocker (propranolol 0.5 mg/kg, orally). When needed, on the pediatric cardiologist's recommendation, sedation was prescribed, using hydroxyzine (1 mg/kg, orally) and midazolam (0.2 mg/kg, orally). After CCTA, children were monitored (blood pressure, pulse) for 3 hours in the pediatric cardiology day hospital unit. The CT pediatric protocol does not require general anesthesia in our institution.
CT Technical Parameters
CCTA was performed on a single-source 512-slice CT (Revolution CT, General Electric Healthcare [GE], Milwaukee) using a wide detector aperture (160 mm), iterative reconstruction algorithm (Asir-V with 50% strength), and specific reconstruction software reducing coronary motion artifacts (SnapShot Freeze).
A prospective ECG-triggered axial technique was performed within a single heartbeat for all patients. Low kV values were selected to maximize iodine contrast to noise ratio (70 kV for children weighing <12 kg; 80 kV for >12 kg and <35 kg; 100 kV for >35 kg). 10 All patients were injected with an iodinated contrast medium (Iomeron 400 mg/mL at 2 mL per kg intravenously, Bracco s.p.a, Milan, Italy) followed by intravenous 10 mL of saline solution. Injection was manually triggered under the radiologist's supervision. Contrast material was infused with flow rates of 4, 3, or 1.5 mL/s through respectively 20, 22, or 24g intravenous antecubital catheters, selected on body size, and prioritizing smallest gauges.
Cardiac Gating Parameters
For every combination of patient's HR and HR variability, a specific acquisition scheme was designed to deliver irradiation at the best theoretical phase within the cardiac cycle. It was made up of one central phase, receiving the maximum irradiation dose (for an optimal image quality); and secondary phases, receiving only a fraction of this maximum dose (with reduced image quality).
To determine the position of the central phase within the cardiac cycle, we took the following factors into consideration: (1) a diastolic acquisition for patients with HR below 80 bpm, (2) a systolic acquisition for patients with HR above 80 bpm, (3) a widened acquisition window for patients with HR higher than 80 bpm or HR variability defined as variable or irregular, and (4) a shifting acquisition window towards the end of the R-R interval on the ECG with increasing HR (Figure 1 ).
Secondary phases which included between 25% and 85% of R-R interval were acquired with a reduced dose (20% of mA). The beginning (0%-25%) and the end (85%-100%) of R-R interval was not acquired (mA set to 0%).
Patient's HR variability was defined as (1) irregular when HR variability exceeded 6 bpm at least 4 times during ECG recording, (2) variable when HR variability exceeded 6 bpm 2 to 3 times during ECG recording, and (3) stable, otherwise.
Following these literature recommendations, a 15-scenario protocol was drafted as illustrated in Figure 2 . Each irradiation scheme was optimized for a given HR range and HR variability. To ease its implementation in clinical routine, the Autogating system (GE Healthcare, Milwaukee) was used. It consists in an automatic selection among the 15 schemes, based on patient's ECG, and following the rules defined on the abscissa and ordinate of 
Irradiation
The dose delivered to patients was evaluated in terms of CT dose index and dose-length product. Effective doses were derived from chest conversion factors by Deak et al 23 using the following formula.
ED mSv DLP mGy cm k mSv mGy cm
The CT dose index, dose-length product, and conversion factor were expressed for a 32 cm body phantom reference.
Image Analysis
Reconstructed images were evaluated independently by 2 radiologists with 10 and 20 years of experience in cardiovascular imaging, respectively.
General image quality for diagnosis, noise perception in the main phase, motion and injection artifacts, were evaluated. All coronary segments were reviewed and gathered under the 4 main coronary artery groups, for scoring: right coronary artery (segments 1-4), left anterior descending artery (segments 6-10), left circumflex artery (segment [11] [12] [13] [14] [15] , and left main coronary artery (segment 5). Every metric and the ability to visualize the entire coronary course were assessed by both radiologists following precise scoring criteria derived from previous publications 24 and reported in Table 1 . Interobserver agreements were evaluated, and the mean score given by the 2 observers was finally considered.
The ability of CCTA to answer the initial clinical question was qualitatively evaluated by both radiologists (yes, partially, and no) taking into account: visualization of the ostia, presence of ostial stenosis, plication aspects, retrosternal course, presence and length of intramyocardial course, anomalous course or origins of coronary arteries involving potential compression between the aorta and pulmonary trunk ( Figures 5 through 7) .
Statistical Analysis
Patient's characteristics were described with proportions for categorical variables and as mean±SD for quantitative variables.
Correlations between the score quantifying image quality, and cardiac parameters, age, dose (CT dose index), noise, and artifacts were calculated using the Spearman correlation coefficient. Correlation strength was expressed using Evans classification. 25 CIs were computed using the Fisher z transformation. Interobserver agreement was assessed with weighted kappa coefficients, using Landis and Koch criteria to characterize strength agreement. 26 Statistical analyses were performed at a conventional 2-tailed α level of 0.05 using SAS version 9.2 (SAS Institute, Cary, NC).
RESULTS
Fifty pediatric patients (24 females, 26 males, 6.1±4.9 years old) were prospectively enrolled in the COROPE- 
Figure 2. ECG-triggering patterns for every heart rate (HR) and HR variability combination (15 possibilities).
The figure shows X-ray tube current variations (ie, dose modulation) within a patient's cardiac cycle. The red line represents the central phase that receives the maximum dose for optimal image quality. Other cardiac phases (dark blue line) only receive 20% of the maximum dose producing reduced image quality. Phases from 0% to 25% and 85% to 100% are never acquired (light blue line).
DIA clinical trial ( Table 2 ). The underlying CHD requiring CCTA were, in descending order, transposition of the great arteries (n=13), tetralogy of Fallot (n=12), anomalous origin of coronary arteries (n=10, including 5 case of abnormal left coronary artery arising from the pulmonary artery), complex CHD (n=7), anomalous course of coronary arteries (n=4), ventricular septal defects (n=3), and post-heart transplant checkup (n=1). All eligible children participated in the study, as no contraindication for CCTA occurred and all families gave their informed consent. All children received a β-blocker (propranolol 0.5 mg/kg, orally) and sedation with hydroxyzine (1 mg/kg, orally). An additional sedation by midazolam (0.2 mg/kg, orally) was necessary for 25 This case will be further discussed in Figure 5 . The axial (A), sagittal-oblique (B), and curved multiplanar (C) systolic reconstructions show a severe compression of the right ostium (white arrows), and of the RCA proximal segment (black arrows) between the aorta and the pulmonary artery. The axial (D), sagittal-oblique (E), and curved multiplanar (F) diastolic reconstructions reveal a lesser degree of these compressions, highlighting the importance of multiple phase acquisitions for dynamic information. We note the increase of noise between the 2 phases, due to the dose decrease between main and secondary acquisitions (100% and 20% of dose, respectively).
children, all aged <6 years old. No child required underwent general anesthesia. No adverse effect related to β-blockers, sedation, and the CCTA itself was reported.
Between 1 and 7 exams were conducted with each of the 15 scan protocols, and no deviation between expected and actual irradiation schemes was observed.
The mean HR was 89±26 bpm under premedication. Patient's HR dropped by 3.4±13.8 bpm on average, following the β-blocker administration.
All performed CCTA were adequate to fully answer the clinical question using an effective dose inferior to 1 mSv (0.97±0.34 mSv). Correlations between image quality and other parameters are presented in Table 3 . A moderate correlation was found between image quality degradation and image noise (r=0.44; P<0.01) or motion artifacts (r=0.48; P<0.01). A weak correlation with injection artifacts was also reported (r=0.36; P<0.01). Very weak to no correlation were found between image quality and cardiac parameters including mean HR (r=−0.19; P=0. 19) , maximum HR (r=−0.13; P=0.34), minimum HR (r=−0.16; P=0.27), and HR variability (r=0.00; P=0.99). No significant differences in visualization of left and right coronary artery segments were reported with 91%, 91%, 92%, and 91% of right coronary artery, left main coronary artery, left anterior descending artery, and left circumflex artery, respectively evaluated as good or excellent (Table 4 ). The entire length of the coronary tree, including proximal, middle, and distal segments, could be visualized in 100% of cases. A total of 46 coronary 
Figure 4. Coronary computed tomography angiography (CCTA) performed for abnormal left coronary artery arising from the pulmonary artery (ALCAPA) suspicion on a 9-year-old girl (heart rate [HR]=78 bpm, irregular HR variability=18 bpm).
Different phases are presented here: (A) at 25%, (B) at 50%, and (C) at 80% of the R-R interval. Maximum dose is delivered from 70% to 80%. On this main phase (C), the left coronary origin is observable. This is not the case at 40% of the R-R interval (B) because of important motion artifacts.
trees could be reconstructed with a score of 3 or more in every segment (good or excellent evaluation). The remaining 4 coronary trees had 1 segment or more with a score of 2 (moderately blurred, just acceptable for evaluation). No coronary tree with a nonevaluative segment was reported. The effective doses delivered to patients were not different among each age group (Table 5) 
DISCUSSION
The COROPEDIA clinical trial assessed the feasibility and the performance of a selective multiphasic CCTA at low dose, from a cohort of 50 children with CHD requiring coronary artery imaging in their clinical follow-up. We used a wide detector single-source CT scanner, combined with a specific cardiac phase selection protocol, designed from a comprehensive literature review. To our knowledge, this study is the first to prospectively test a selective multiphasic acquisition protocol based on cardiac rhythm and variability. This approach gave the advantage of multiphasic acquisitions (more information for the clinician and reduced risk of acquiring cardiac phase with motion artifacts) as well as keeping dose to submillisievert levels by being selective on the multiphasic aspect.
Phase Selection as a Function of the Patient's Cardiac Characteristics
Performing CCTA on adults has been extensively studied. 20, 21, 24, 27 In a pediatric population, coronary artery diameters are smaller, velocities, and HR are higher; and the variability of cardiac rhythms from one patient to another is an important consideration (from 42 to 185 bpm in this study). Therefore, targeting the same cardiac phase for all patients represents a limiting factor of CCTA image quality. 16, 28, 29 As a result, to maximize chances of triggering the acquisition when coronary arteries are relatively motionless, it is crucial to adapt duration and positioning of the acquisition window within the R-R interval. Considering HR below 80 bpm, the least motion of the coronary artery is reached from mid to end diastole, when blood is passively flowing from the lungs into the left ventricle while the myocardium is at rest, 20, 21 but with increasing HR, this stability phase tends to shorten. The end-systolic phase then becomes the longest motionless phase. 11, [19] [20] [21] [22] 28 Thereby, a switch from a diastolic to a systolic acquisition should be applied for patients with HR above 70 to 90 bpm. 11, [19] [20] [21] 27 In addition, as diastolic diastasis shortens with increasing HR, both diastolic and systolic stability phases tend to slightly shift towards the end of the cycle. 19, 21, 28 Additionally, tachycardia and HR variability involve higher chances of missing the targeted phase, so that a wider acquisition window is recommended. 24 Independently of HR, cardiac phases between 0% to 25% and 85% to 100% of R-R interval present important motion, thus these should not be acquired, preserving the patient from unnecessary irradiation.
20,21
Selective Multiphasic ECG-Triggered Acquisitions
This protocol resulted in a mean delivered dose inferior to 1 mSv, with the ability to fully answer the clinical question for all patients. Very few CCTA studies have been conducted with pediatric patients with CHD. Most of them reported doses from 1.4 to 4 mSv. 6, 15 Some recent studies went further in dose reduction. Paul et al 18 reported a dose of 0.26 mSv with end-systolic monophasic acquisitions. In 13% of cases, CCTA had to be performed again because of suboptimal image quality and inaccurate diagnosis. Habib Geryes et al 13 used doses ranging from 0.8 to 3.1 mSv and reported 15% of examinations with significant artifacts. Finally with an effective dose of 1.3 mSv, Ben Saad et al 11 counted 11% of CCTA with no possible diagnosis, because of insufficient contrast, noise, respiratory motion, or cardiac motion. Neither suboptimal image quality nor sec- CTDI indicates computed tomography dose index; and HR, heart rate. *r s =Spearman rank correlation coefficient. †A P value for a H 0 r s =0; a P value <0.05 indicates a correlation coefficient significantly different from 0.
‡Minimum, maximum, and mean heart rates recorded during the acquisition.
§HR variability is defined as the difference between the average HR and the higher HR deviation recorded during the acquisition. ond acquisition occurred in the COROPEDIA trial (0%; CI [0%-7.11%]). This differs significantly from the results previously discussed. Two reasons could explain this difference: first, triggering acquisitions during the coronary artery motionless phase, defined as a function of the patient's cardiac characteristics, increases chances of getting images free of motion artifacts. Second, because of multiphasic approach, cardiac phases from 25% to 85% of the R-R interval were reconstructed, even when acquired with low signal (only 20% of the dose was delivered during secondary phases). This expands chances of getting an interpretable phase whenever the main phase did not provide the expected results (coronary motion artifacts, sudden child's agitation, or crying). This was the case in 6 patients of our study, in whom a low signal phase presented higher diagnosis quality than the main phase. The HR of these patients, all between 76 and 85 bpm, suggests that 80 bpm might not be the optimum limit to switch from diastolic to systolic acquisitions. Yet, no clear trend implying increasing or lowering this threshold appeared in our study, suggesting that the best phase in patients with HR close to 80 bpm might be either diastolic or systolic, depending on individuals.
Delivered Doses
No differences in effective doses were reported, regardless of patients' age group. Dose-length product increased with body size, due to higher scan length and X-ray absorption in larger bodies. Conversely, conversion factors decreased as a function of the patient's age because of lower dose contribution to radiosensitive organs (lung, liver, etc) because of increased patient cross section. 23 Therefore, in our study, effective doses remained steady through age groups.
Image Quality
Image quality slightly improved with age, while noise and motion artifacts were reduced. Fewer uncontrolled movements and larger size of cardiac structures could lead to these slight differences. For the 3 patients with adequate image quality only, motion artifacts remained the limiting factor, as reported previously. 11, 19 In our study, image noise and injection artifacts correlated to image quality; however, this did not lead to any inferiority in diagnostic quality, unlike other studies. 11 The lack of breath holding did not lead to any limitation in image quality, neither. Children had the peripheral intravenous catheter placed before moving to the imaging department to avoid patient's agitation. Acquisitions only started when the child was calm on the table, to reduce respiratory artifacts. Additionally, coronary arteries shifting by respiration should be less than by cardiac pulsation.
12,30
Correlations Between Image Quality and Patients' Cardiac Characteristics
Some studies reported a correlation between HR 31 or HR variability 27 and image quality. This is not the case in our study, and the CI from our analysis suggests that it is unlikely that an important correlation exists between image quality and cardiac parameters. Acquisition windows adapted to patient's HR and HR variability together with the multiphasic aspect of our acquisitions might have helped to reduce the negative impact of high HR and HR variability on image quality. In this study, we used the existing protocol in our institution, for example, children with an HR above 70 bpm received a single dose of β-blocker. Our results suggest that β-blockers might not be necessary, but this needs to be evaluated in further studies.
Coronary Artery Segment Visualization
Surprisingly, we found no significant visualization differences between right coronary artery, left main coronary artery, left circumflex artery, and left anterior descending artery. Other studies have reported that left circumflex artery and right coronary artery were more subject to myocardium movements, resulting in difficulties in visualizing these particular segments. 16, 17, 29 About lower HR, a common point of least motion is established for all coronary segments at mid diastole. Nevertheless, this common interval no longer exists at higher HR (>75 bpm). 16, 21, 28 Therefore, we made the assumption that this lack of visual quality differences between coronary segments in our study might be because of the multiphasic aspect of the protocol. Regardless of patient's HR, every coronary segment might be visualized in its own motionless phase, in case the main acquisition did not provide satisfactory vessel visualization.
Limitations
This study aimed to represent a typical pediatric population requiring CCTA, as part of their follow-up. Patients were gathered into 4 homogeneous groups, for analysis. Yet, the heterogeneity of our CHD population may represent a limit of the study. Although our cohort only included pediatric patients, CCTA care management is different when considering newborns, infants, or adolescents. Our study revealed important variability in terms of cardiac parameters, breathholding capacities, and morphology. However, the use of a multiphasic protocol, with the acquisition window adapted to patient's HR and HR variability led to significant diagnostic confidence for clinicians while maintaining low radiation dose for all patients. The COROPEDIA clinical trial assessed this possibility. Yet, additional studies are necessary to refine this model, leading to fully personalized CCTA examinations for children with CHD.
Conclusions
For the first time in a pediatric population, the CORO-PEDIA clinical trial assessed the feasibility and the performance of a selective multiphasic CCTA at low dose, based on prospectively ECG-triggered examinations. This study defined a comprehensive set of parameters to perform pediatric CCTA as a function of a patient's cardiac characteristics. Despite difficult acquisition conditions in pediatrics (HR up to 185 bpm, irregular rhythms, and coronary artery diameters under 2 mm), all examinations fully answered the clinical question, for a radiation dose equivalent to <4 months of natural background irradiation.
